EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 244 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2019. The put-call ratio across all filers is 8.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $239,000 | -29.7% | 7,705 | -6.9% | 0.01% | -18.2% |
Q1 2022 | $340,000 | -5.6% | 8,280 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $360,000 | -15.9% | 8,280 | -3.2% | 0.01% | -38.9% |
Q3 2021 | $428,000 | -20.6% | 8,552 | 0.0% | 0.02% | -18.2% |
Q2 2021 | $539,000 | -37.8% | 8,552 | -8.3% | 0.02% | -42.1% |
Q1 2021 | $867,000 | +3.7% | 9,330 | 0.0% | 0.04% | 0.0% |
Q4 2020 | $836,000 | -25.9% | 9,330 | -14.5% | 0.04% | -34.5% |
Q3 2020 | $1,128,000 | +21.9% | 10,918 | -6.6% | 0.06% | +18.4% |
Q2 2020 | $925,000 | +16.9% | 11,692 | -14.5% | 0.05% | +2.1% |
Q1 2020 | $791,000 | +25.6% | 13,669 | +17.1% | 0.05% | +60.0% |
Q4 2019 | $630,000 | -4.4% | 11,677 | -7.4% | 0.03% | -11.8% |
Q3 2019 | $659,000 | +7.9% | 12,611 | -0.2% | 0.03% | +3.0% |
Q2 2019 | $611,000 | +772.9% | 12,642 | +806.9% | 0.03% | +725.0% |
Q1 2019 | $70,000 | +52.2% | 1,394 | +78.0% | 0.00% | +33.3% |
Q4 2018 | $46,000 | +7.0% | 783 | +19.4% | 0.00% | +50.0% |
Q3 2018 | $43,000 | – | 656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
AtonRa Partners | 11,505 | $472,000 | 0.26% |